Copyright Reports & Markets. All rights reserved.

Global Recombinant Humanized Collagen Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Recombinant Humanized Collagen Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Type I Collagen
    • 1.3.3 Type Ⅲ Collagen
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Recombinant Humanized Collagen Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Food Health Care
    • 1.4.3 Beauty Cosmetics
    • 1.4.4 Biomedical Materials
  • 1.5 Global Recombinant Humanized Collagen Market Size & Forecast
    • 1.5.1 Global Recombinant Humanized Collagen Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Recombinant Humanized Collagen Sales Quantity (2020-2031)
    • 1.5.3 Global Recombinant Humanized Collagen Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 ACROBiosystems
    • 2.1.1 ACROBiosystems Details
    • 2.1.2 ACROBiosystems Major Business
    • 2.1.3 ACROBiosystems Recombinant Humanized Collagen Product and Services
    • 2.1.4 ACROBiosystems Recombinant Humanized Collagen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 ACROBiosystems Recent Developments/Updates
  • 2.2 FineTest
    • 2.2.1 FineTest Details
    • 2.2.2 FineTest Major Business
    • 2.2.3 FineTest Recombinant Humanized Collagen Product and Services
    • 2.2.4 FineTest Recombinant Humanized Collagen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 FineTest Recent Developments/Updates
  • 2.3 Evonik
    • 2.3.1 Evonik Details
    • 2.3.2 Evonik Major Business
    • 2.3.3 Evonik Recombinant Humanized Collagen Product and Services
    • 2.3.4 Evonik Recombinant Humanized Collagen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Evonik Recent Developments/Updates
  • 2.4 Giant Biogene
    • 2.4.1 Giant Biogene Details
    • 2.4.2 Giant Biogene Major Business
    • 2.4.3 Giant Biogene Recombinant Humanized Collagen Product and Services
    • 2.4.4 Giant Biogene Recombinant Humanized Collagen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Giant Biogene Recent Developments/Updates
  • 2.5 Shanxi Jinbo Bio-Pharmaceutical
    • 2.5.1 Shanxi Jinbo Bio-Pharmaceutical Details
    • 2.5.2 Shanxi Jinbo Bio-Pharmaceutical Major Business
    • 2.5.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product and Services
    • 2.5.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments/Updates
  • 2.6 Jiangsu JLand Biotech
    • 2.6.1 Jiangsu JLand Biotech Details
    • 2.6.2 Jiangsu JLand Biotech Major Business
    • 2.6.3 Jiangsu JLand Biotech Recombinant Humanized Collagen Product and Services
    • 2.6.4 Jiangsu JLand Biotech Recombinant Humanized Collagen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Jiangsu JLand Biotech Recent Developments/Updates
  • 2.7 Jiangsu Chuangjian Medical Technology
    • 2.7.1 Jiangsu Chuangjian Medical Technology Details
    • 2.7.2 Jiangsu Chuangjian Medical Technology Major Business
    • 2.7.3 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product and Services
    • 2.7.4 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Jiangsu Chuangjian Medical Technology Recent Developments/Updates
  • 2.8 JY-RAN
    • 2.8.1 JY-RAN Details
    • 2.8.2 JY-RAN Major Business
    • 2.8.3 JY-RAN Recombinant Humanized Collagen Product and Services
    • 2.8.4 JY-RAN Recombinant Humanized Collagen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 JY-RAN Recent Developments/Updates

3 Competitive Environment: Recombinant Humanized Collagen by Manufacturer

  • 3.1 Global Recombinant Humanized Collagen Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Recombinant Humanized Collagen Revenue by Manufacturer (2020-2025)
  • 3.3 Global Recombinant Humanized Collagen Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Recombinant Humanized Collagen by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Recombinant Humanized Collagen Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Recombinant Humanized Collagen Manufacturer Market Share in 2024
  • 3.5 Recombinant Humanized Collagen Market: Overall Company Footprint Analysis
    • 3.5.1 Recombinant Humanized Collagen Market: Region Footprint
    • 3.5.2 Recombinant Humanized Collagen Market: Company Product Type Footprint
    • 3.5.3 Recombinant Humanized Collagen Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Recombinant Humanized Collagen Market Size by Region
    • 4.1.1 Global Recombinant Humanized Collagen Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Recombinant Humanized Collagen Consumption Value by Region (2020-2031)
    • 4.1.3 Global Recombinant Humanized Collagen Average Price by Region (2020-2031)
  • 4.2 North America Recombinant Humanized Collagen Consumption Value (2020-2031)
  • 4.3 Europe Recombinant Humanized Collagen Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Recombinant Humanized Collagen Consumption Value (2020-2031)
  • 4.5 South America Recombinant Humanized Collagen Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Recombinant Humanized Collagen Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Recombinant Humanized Collagen Sales Quantity by Type (2020-2031)
  • 5.2 Global Recombinant Humanized Collagen Consumption Value by Type (2020-2031)
  • 5.3 Global Recombinant Humanized Collagen Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Recombinant Humanized Collagen Sales Quantity by Application (2020-2031)
  • 6.2 Global Recombinant Humanized Collagen Consumption Value by Application (2020-2031)
  • 6.3 Global Recombinant Humanized Collagen Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Recombinant Humanized Collagen Sales Quantity by Type (2020-2031)
  • 7.2 North America Recombinant Humanized Collagen Sales Quantity by Application (2020-2031)
  • 7.3 North America Recombinant Humanized Collagen Market Size by Country
    • 7.3.1 North America Recombinant Humanized Collagen Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Recombinant Humanized Collagen Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Recombinant Humanized Collagen Sales Quantity by Type (2020-2031)
  • 8.2 Europe Recombinant Humanized Collagen Sales Quantity by Application (2020-2031)
  • 8.3 Europe Recombinant Humanized Collagen Market Size by Country
    • 8.3.1 Europe Recombinant Humanized Collagen Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Recombinant Humanized Collagen Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Recombinant Humanized Collagen Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Recombinant Humanized Collagen Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Recombinant Humanized Collagen Market Size by Region
    • 9.3.1 Asia-Pacific Recombinant Humanized Collagen Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Recombinant Humanized Collagen Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Recombinant Humanized Collagen Sales Quantity by Type (2020-2031)
  • 10.2 South America Recombinant Humanized Collagen Sales Quantity by Application (2020-2031)
  • 10.3 South America Recombinant Humanized Collagen Market Size by Country
    • 10.3.1 South America Recombinant Humanized Collagen Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Recombinant Humanized Collagen Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Recombinant Humanized Collagen Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Recombinant Humanized Collagen Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Recombinant Humanized Collagen Market Size by Country
    • 11.3.1 Middle East & Africa Recombinant Humanized Collagen Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Recombinant Humanized Collagen Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Recombinant Humanized Collagen Market Drivers
  • 12.2 Recombinant Humanized Collagen Market Restraints
  • 12.3 Recombinant Humanized Collagen Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Recombinant Humanized Collagen and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Recombinant Humanized Collagen
  • 13.3 Recombinant Humanized Collagen Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Recombinant Humanized Collagen Typical Distributors
  • 14.3 Recombinant Humanized Collagen Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Recombinant Humanized Collagen market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    Recombinant human collagen is a genetically engineered strain constructed by molecular biology method. The collagen type III was purified by more than a dozen separation process. The product is sterilized under GMP conditions and lyophilized to obtain active product.
    This report is a detailed and comprehensive analysis for global Recombinant Humanized Collagen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Recombinant Humanized Collagen market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
    Global Recombinant Humanized Collagen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
    Global Recombinant Humanized Collagen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
    Global Recombinant Humanized Collagen market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Recombinant Humanized Collagen
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Recombinant Humanized Collagen market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ACROBiosystems, FineTest, Evonik, Giant Biogene, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu JLand Biotech, Jiangsu Chuangjian Medical Technology, JY-RAN, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Recombinant Humanized Collagen market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Type I Collagen
    Type Ⅲ Collagen
    Others
    Market segment by Application
    Food Health Care
    Beauty Cosmetics
    Biomedical Materials
    Major players covered
    ACROBiosystems
    FineTest
    Evonik
    Giant Biogene
    Shanxi Jinbo Bio-Pharmaceutical
    Jiangsu JLand Biotech
    Jiangsu Chuangjian Medical Technology
    JY-RAN
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Recombinant Humanized Collagen product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Recombinant Humanized Collagen, with price, sales quantity, revenue, and global market share of Recombinant Humanized Collagen from 2020 to 2025.
    Chapter 3, the Recombinant Humanized Collagen competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Recombinant Humanized Collagen breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Humanized Collagen market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Humanized Collagen.
    Chapter 14 and 15, to describe Recombinant Humanized Collagen sales channel, distributors, customers, research findings and conclusion.

    Buy now